Page 21 - திரிவேதி பள்ளி ஆஃப் உயிர் அறிவியல் இல் அசோகா பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from திரிவேதி பள்ளி ஆஃப் உயிர் அறிவியல் இல் அசோகா பல்கலைக்கழகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In திரிவேதி பள்ளி ஆஃப் உயிர் அறிவியல் இல் அசோகா பல்கலைக்கழகம் Today - Breaking & Trending Today

Patralekha Chatterjee | Why trust needs to be the key word in 2021


Patralekha Chatterjee | Why trust needs to be the key word in 2021
Published : Jan 7, 2021, 4:00 am IST
Updated : Jan 7, 2021, 4:00 am IST
Opacity in decision-making, attempts to gloss over mistakes or polarise the populace on any count will punch holes in the trust narrative
 The controversy, however, is more about the drug regulator’s emergency approval to the second coronavirus vaccine, the indigenously produced Covaxin, before critical efficacy data of the third phase of clinical trials are out.
India has a good story to tell when it comes to vaccines it produces more than 60 per cent of all vaccines sold across the globe. Why then has India’s final approval of two Covid-19 vaccines kicked up such a storm, with many respected health experts and scientists calling it a hasty decision? ....

Uttar Pradesh , Leena Menghaney , Shahid Jameel , National Institute Of Virology , World Health Assembly , Aligarh Muslim University , Trivedi School Of Biosciences At Ashoka University , Indian Council Of Medical Research , Astrazeneca Oxford University , European Medicines Agency , Serum Institute Of India , Serum Institute , Hyderabad Based Bharat Biotech , Indian Council , Medical Research , National Institute , Bharat Biotech , Drugs Controller General , Trivedi School , South Asia , Sans Fronti , Jamia Milia Islamia , Phase 3 Trail Pending , Clinical Trails , உத்தர் பிரதேஷ் , ஷாஹித் ஜமீல் ,

Coronavirus: India′s approval of local vaccines draws criticism | Asia| An in-depth look at news from across the continent | DW


India prepares for massive COVID-19 vaccination drive
Intense concerns
The All India Drug Action Network, a nonprofit health watchdog, said it was shocked to see approval for Covaxin, a vaccine candidate with a lack of peer-reviewed safety and efficacy data.
In light of the intense concerns arising from the absence of efficacy data and hence the limited regulatory review of the vaccine candidate, the implications of public rollout of an untested product, and lack of transparency, we urge the DCGI to reconsider the recommendations of the expert committee in granting the approval to Covaxin, it said.
Virologists like Shahid Jameel, director of the Trivedi School of Biosciences at Ashoka University, said he was confused with the terminology used by the DCGI. ....

United Kingdom , Harsh Vardhan , Nitin Pai , Geraldo Barbosa , Giridhar Babu , Shahid Jameel , Balram Bhargava , Srinath Reddy , Takshashila Institution , Serum Institute Of India Covishield , National Institute Of Virology , Trivedi School Of Biosciences At Ashoka University , Indian Council Of Medical Research , Health Ministry , India Drug Action Network , Indian Health , Brazilian Association Of Vaccine Clinics , Serum Institute , Oxford University , Public Health Foundation Of India , Drugs Controller General , Bharat Biotech , Indian Council , Medical Research , National Institute , All India Drug Action Network ,

Steady fall in Covid cases point to herd immunity


India could be at a turning point in its life and death battle against Covid-19 with a steady fall in the number of cases combining with the government’s ambitious plans to roll out vaccines at high speed. Virologists say the declining case trajectory may reflect herd immunity taking hold in localised areas of the country.  
Daily new Covid-19 cases in the country have been riding below 20,000 for a number of days and on Monday stood at 16,504. That’s more than six times below the peak hit on September 16 when fresh cases hit 97,784. It was widely forecast in mid-September that India was about to crack a dismal milestone of a record 100,0000 fresh cases a day. Instead, the number of daily cases began slipping. “You can’t miss the trend. I think we have turned a corner,” says virologist Shahid Jameel. ....

United Kingdom , New Delhi , South Africa , Tamil Nadu , Dileep Raman , Lipi Thukral , Dipyaman Ganguly , Gagandeep Kang , Shahid Jameel , Christian Medical College , Department Of Gastrointestinal Sciences , Indian Institute Of Chemical Biology , Trivedi School Of Biosciences At Ashoka University , Institute Of Genomics , Trivedi School , Ashoka University , Severe Acute Respiratory Infections , Indian Institute , South East England , Gastrointestinal Sciences , United Kingdom Returnees , ஒன்றுபட்டது கிஂக்டம் , புதியது டெல்ஹி , தமிழ் நாடு , திலீப் ராமன் , லிப்பி துகிரள் ,